External resources PMC: The physiology of weight loss plateaus during obesity pharmacotherapy , a comprehensive analysis of metabolic adaptation mechanisms during GLP-1 receptor agonist therapy, including appetite feedback coefficients and energy expenditure changes
What are GLP-1s and how do they work
Timing and lifestyle factors Heart rate naturally fluctuates throughout the day, and certain factors can amplify the effects of retatrutide on cardiac rate: Caffeine is an adenosine receptor antagonist that independently increases heart rate
It is recommended that patients seek advice from health experts regarding the FDA-approved GLP-1 drugs for weight loss purposes and lifestyle modifications needed to achieve effective and sustainable weight loss and diabetes control
Tirzepatide-related fatigue may result from several factors including significant caloric restriction due to appetite suppression, delayed gastric emptying affecting nutrient delivery, metabolic changes as the body adjusts to improved glycemic control, potential hypoglycemia (especially when combined with insulin or sulfonylureas), and dehydration from gastrointestinal side effects
some individuals achieve significant weight loss at lower doses, while others tolerate and benefit from higher doses